Behandlung von Metastasen in der Leber in Israel — erhalten Sie 3 personalisierte Klinikempfehlungen

Israel offers advanced treatments for liver metastases. This includes ex vivo liver resection and selective internal radiation therapy. Specialized centers utilize stereotactic radiosurgery and irreversible electroporation for precision. Multidisciplinary tumor boards at JCI-accredited facilities ensure high success rates for complex cases.

• Surgical innovations: Surgeons perform ex vivo resection and ALPPS for complex tumors.
• Locoregional therapies: Techniques include SIRT (Yttrium-90) and transarterial chemoembolization with drug-eluting beads.
• Ablation methods: Irreversible electroporation (NanoKnife) destroys tumors near delicate blood vessels safely.
• Precision radiotherapy: MR-Linac systems at Assuta Medical Center track tumor movement during breathing.

Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky report high patient volumes. Sheba serves 1,900,000 patients annually and leads in TIL immunotherapies. This high volume allows surgeons to master rare procedures like robotic oncologic resections. Specialists like Dr. Ido Nachmany pioneered these robotic techniques for better recovery.

Patient Consensus: Patients value the precision of SBRT which can significantly reduce lesions. Many note that advanced therapies like NanoKnife allow for much faster recovery times.

Inoperable liver metastases are treatable in Israel using advanced locoregional and systemic therapies. Leading JCI-accredited centers specialize in tumor destruction and growth control. These methods often aim to convert unresectable tumors into a state where surgical removal eventually becomes a viable option.

• Targeted chemotherapy: Hepatic arterial infusion (HAI) delivers drugs directly via the liver artery.
• Radioembolization: SIRT uses radioactive yttrium-90 beads to destroy tumors from within.
• Tumor ablation: Techniques like RFA and IRE burn or electrify soft-tissue tumors.
• Embolization protocols: TACE blocks blood supply to tumors while delivering concentrated chemotherapy.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba function as high-volume hubs. Sourasky alone reports a 90% average success rate for oncology treatments. Their specialists often combine local ablation with advanced immunotherapy. This multidisciplinary approach allows them to manage complex cases that surgical-only centers might refuse.

Patient Consensus: Patients note it is important to bring original biopsy slides for review in Israel. They highlight the detailed genomic profiling helps doctors find more effective drug combinations.

Top Israeli hospitals for liver metastases include Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited institutions utilize multidisciplinary teams and advanced techniques like SIRT, radiofrequency ablation, and robotic resections. They consistently rank among the world's best for oncology success and surgical volume.

• Sourasky (Ichilov): Reports a 90% oncology success rate with advanced liver resections.
• Sheba Medical Center: Ranked 7th globally by Newsweek; pioneers robotic and SIRT therapies.
• Hadassah Medical Center: Features a dedicated liver unit led by Professor Rifaat Safadi.
• Assuta Medical Center: Israel's largest private facility performing 92,000 surgeries annually with rapid scheduling.

Bookimed Expert Insight: While many choose Tel Aviv for its volume, Sheba Medical Center offers unmatched expertise in robotic-assisted liver surgery. Professor Ido Nachmany and Dr. Yuri Goldes pioneered these procedures in Israel. This technology allows for more precise tumor removal while preserving more healthy liver tissue compared to traditional methods.

Patient Consensus: Patients emphasize that starting with a documentation review saves weeks of time. They also note that having a coordinator helps navigate busy wards and ensures clear communication with medical staff.

International patients can start treatment in Israel within 1 to 5 days of arrival. Prior to travel, clinics provide preliminary care plans within 24 to 72 hours. Medical facilities like Sourasky and Sheba prioritize international cases to bypass local public wait times for urgent oncology care.

• Preliminary planning: Clinics deliver tailored treatment strategies within 3 to 5 days of record submission.
• Diagnostic speed: Advanced PET-CT and MRI scans typically conclude within 1 to 2 business days.
• Immediate initiation: Surgery or chemoembolization often begins the day after diagnostic confirmation in country.
• Visa processing: Major hospitals issue official invitation letters to fast-track consulate approvals within 2 to 7 days.

Bookimed Expert Insight: Data from Sourasky Medical Center and Sheba Medical Center shows a clear preference for private surgical routes to accelerate care. While Sheba serves over 2 million patients annually, choosing private departments at facilities like Assuta can further reduce administrative wait times by 30%. For complex cases, selecting surgeons like Dr. Menahem Ben-haim, who has over 25 years of experience, ensures the initial consultation and surgical planning happen simultaneously.

Patient Consensus: Patients emphasize that having translated biopsy results and original imaging discs ready can shave days off the process. Many note that treatment for metastatic conditions often starts within 10 days of visa approval when logistics are handled effectively.

A repeat biopsy may not be necessary if Israeli pathologists can verify your original tissue samples. Israeli oncology centers typically require physical glass slides or paraffin blocks for an independent histopathology revision. A written report alone is rarely sufficient for planning complex liver metastasis treatment.

• Histopathology revision: Specialists review original slides to confirm diagnosis without new invasive surgery.
• Physical material: Patients must courier original glass slides and tissue blocks to Israel.
• Mandatory re-biopsy: Required if original samples are too small, degraded, or clinically outdated.
• Biomarker testing: New samples are needed if original tissue lacks KRAS, NRAS, or BRAF data.

Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba prioritize precision. While many patients hope to avoid a new procedure, our data shows a high frequency of histopathology revisions. For liver metastases, surgeons often require specific molecular markers to determine if a patient qualifies for advanced therapies like SIRT or specialized liver resections. Sending your physical slides at least 4 weeks before your flight can save you significant time and hospital stay costs upon arrival.

Patient Consensus: Patients note that even fresh biopsies from highly developed countries are often repeated in Israel to meet local laboratory protocols. Many wish they had known to ship their physical slides via medical courier well before their first consultation to avoid diagnostic delays.